Availability of Laboratory Diagnosis of Gonorrhoea and Its Meaning in Case Reporting in Shandong Province, China
Xinlong Chen,Yanling Gan,Dianchang Liu
DOI: https://doi.org/10.2147/CCID.S402676
2023-04-01
Abstract:Xinlong Chen, 1 Yanling Gan, 2 Dianchang Liu 2 1 Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610072, People's Republic of China; 2 Department of STI and Leprosy Prevention and Control, Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250022, People's Republic of China Correspondence: Dianchang Liu, Tel +86 531-87298850, Email Background: Gonorrhea, caused by the bacterium Neisseria gonorrhoeae (NG), is a major public health concern worldwide. Aim of the Study: The aim of this study is to understand the availability of laboratory diagnosis of gonorrhoea in Shandong province and its meaning in case reporting. Methods: Two surveys were conducted among hospitals providing clinical services for sexually transmitted infection (STI) in Shandong Province in 2012 and 2018. The availability of laboratory tests for NG and distribution of reported gonorrhea cases were compared among different hospitals provided clinical services for STI in Shandong province. Descriptive analysis and Chi-square were used for statistical analysis. Results: Smear, culture and PCR tests for NG were used among 301(74.69%), 123(30.52%), 43(10.67%) hospitals in 2012 and 356(74.48%), 176(36.82%) and 73(15.27%) hospitals in 2018, respectively. Significant differences were observed in the availability of smear among hospitals at different levels (X 2 =12.159, p=0.000) and with different affiliations (X 2 =4.551, p=0.033) in 2018. Significant differences were observed in the availability of culture and PCR tests among hospitals at different levels both in 2012 (X 2 =34.532, p=0.000; X 2 =7.380, p=0.007) and 2018 (X 2 =49.820, p=0.000; X 2 =21.658, p=0.000). The availability of culture and PCR tests for NG among hospitals in 2018 was higher than that in 2012 (X 2 =3.870, p=0.049; X 2 =4.050, p=0.044). More hospitals reported gonorrhea cases in 2018 than in 2012 (X 2 =6.768, p=0.009). A significant difference was observed in distribution of case reporting among hospitals at different levels in 2018 (X 2 =6.975, p=0.008) and among different types of hospital both in 2012 (X 2 =52.362, p=0.000) and 2018 (X 2 =74.478, p=0.000). Conclusion: Poor availability of NG laboratory tests affects case reporting, and which is a crucial reason leading to underreporting of gonorrhea cases in Shandong province. Keywords: gonorrhea, availability, laboratory tests, underreporting Gonorrhea, caused by the bacterium Neisseria gonorrhoeae (NG), is a major public health concern worldwide. It was estimated that 82 million new case were infected by NG worldwide in 2020. 1 The 2016 global prevalence estimates in women were: gonorrhoea 0.9% and syphilis 0.5%. 2 The reported incidence of gonorrhea was higher than that of syphilis. In China, syphilis and gonorrhea belong to the second-class infectious diseases, according to the Infectious Disease Prevention Act of China. 3 The incidence rates of gonorrhea were on the rise from 2011 to 2021. The annual percentage change was 2.56% for gonorrhea. 4 A study found that the positive rate of syphilis and N. gonorrhoeae among women of reproductive age was 0.73% and 0.06%. 5 Gonorrhea is still among the top five notifiable infectious diseases in China. The reported incidence of gonorrhea was 9.59 cases per 100,000 residents in 2018. 6 Gonorrhea is still one of the major infectious diseases that should be concerned. In the absence of treatment, gonorrhea can lead to pelvic inflammatory disease, infertility and an increased risk of transmission of human immunodeficiency virus. 7 Studies indicate that NG is rapidly becoming untreatable with decreased ceftriaxone and azithromycin susceptibility. 8–10 Dual therapy with ceftriaxone and azithromycin is currently recommended for the treatment of gonorrhea in Thailand. 11 In addition, tolerance to ceftriaxone was found in clinical samples. 12 However, if the surveillance data cannot interpret the current situation of gonorrhea epidemic, misleading may be inevitable in policy making for gonorrhea prevention and control. Many factors may affect the integrity and accuracy of surveillance data. Gonorrhea may be asymptomatic in 40% of men and more than half of women. 13 A survey found that 81% to 98% of individuals with chlamydia and gonorrhea infections would be undiagnosed and u -Abstract Truncated-
dermatology